These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11665587)

  • 1. Design and synthesis of peptide antagonists and inverse agonists for G protein-coupled receptors.
    Cowell SM; Balse-Srinivasan PM; Ahn JM; Hruby VJ
    Methods Enzymol; 2002; 343():49-72. PubMed ID: 11665587
    [No Abstract]   [Full Text] [Related]  

  • 2. Design of peptide agonists.
    Hruby VJ; Agnes RS; Cai C
    Methods Enzymol; 2002; 343():73-91. PubMed ID: 11665596
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug analysis based on signaling responses to G-protein-coupled receptors.
    Harden TK; Boyer JL; Dougherty RW
    J Recept Signal Transduct Res; 2001; 21(2-3):167-90. PubMed ID: 11757682
    [No Abstract]   [Full Text] [Related]  

  • 4. The family of G-protein-coupled receptors.
    Strader CD; Fong TM; Graziano MP; Tota MR
    FASEB J; 1995 Jun; 9(9):745-54. PubMed ID: 7601339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Considerations in the evaluation of inverse agonism and protean agonism at G protein-coupled receptors.
    Chidiac P
    Methods Enzymol; 2002; 343():3-16. PubMed ID: 11665576
    [No Abstract]   [Full Text] [Related]  

  • 6. Creation and functional screening of a multi-use peptide library.
    Jayawickreme CK; Graminski GF; Quillan JM; Lerner MR
    Proc Natl Acad Sci U S A; 1994 Mar; 91(5):1614-8. PubMed ID: 8127853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation and inhibition of G protein-coupled receptors by cell-penetrating membrane-tethered peptides.
    Covic L; Gresser AL; Talavera J; Swift S; Kuliopulos A
    Proc Natl Acad Sci U S A; 2002 Jan; 99(2):643-8. PubMed ID: 11805322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of constitutive G protein-coupled receptor activity for drug discovery.
    Chen G; Way J; Armour S; Watson C; Queen K; Jayawickreme CK; Chen WJ; Kenakin T
    Mol Pharmacol; 2000 Jan; 57(1):125-34. PubMed ID: 10617687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional mapping of the ligand binding sites of G-protein coupled receptors.
    Fong TM; Strader CD
    Med Res Rev; 1994 Jul; 14(4):387-99. PubMed ID: 8084202
    [No Abstract]   [Full Text] [Related]  

  • 10. Strategies to identify ligands for orphan G-protein-coupled receptors.
    Milligan G
    Biochem Soc Trans; 2002 Aug; 30(4):789-93. PubMed ID: 12196198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inverse agonism at heptahelical receptors: concept, experimental approach and therapeutic potential.
    Daeffler L; Landry Y
    Fundam Clin Pharmacol; 2000; 14(2):73-87. PubMed ID: 10796054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inverse agonism and the regulation of receptor number.
    Milligan G; Bond RA
    Trends Pharmacol Sci; 1997 Dec; 18(12):468-74. PubMed ID: 9458695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific peptide probes for G-protein interactions with receptors.
    Hamm HE; Rarick HM
    Methods Enzymol; 1994; 237():423-36. PubMed ID: 7935015
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthetic peptides to mimic the role of GTP binding proteins in membrane traffic and fusion.
    Law GJ; Northrop AJ
    Ann N Y Acad Sci; 1994 Mar; 710():196-208. PubMed ID: 8154748
    [No Abstract]   [Full Text] [Related]  

  • 15. 2-[N-Acylamino(C1-C3)alkyl]indoles as MT1 melatonin receptor partial agonists, antagonists, and putative inverse agonists.
    Spadoni G; Balsamini C; Bedini A; Diamantini G; Di Giacomo B; Tontini A; Tarzia G; Mor M; Plazzi PV; Rivara S; Nonno R; Pannacci M; Lucini V; Fraschini F; Stankov BM
    J Med Chem; 1998 Sep; 41(19):3624-34. PubMed ID: 9733487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orphan G-protein-coupled receptors: the next generation of drug targets?
    Wilson S; Bergsma DJ; Chambers JK; Muir AI; Fantom KG; Ellis C; Murdock PR; Herrity NC; Stadel JM
    Br J Pharmacol; 1998 Dec; 125(7):1387-92. PubMed ID: 9884064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences between natural and recombinant G protein-coupled receptor systems with varying receptor/G protein stoichiometry.
    Kenakin T
    Trends Pharmacol Sci; 1997 Dec; 18(12):456-64. PubMed ID: 9458693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional screening of multiuse peptide libraries using melanophore bioassay.
    Jayawickreme CK; Jayawickreme SP; Lerner MR
    Methods Mol Biol; 1998; 87():119-28. PubMed ID: 9523266
    [No Abstract]   [Full Text] [Related]  

  • 19. G-protein-coupled receptors: what limits high-affinity agonist binding?
    Hoare SR
    Trends Pharmacol Sci; 2000 Mar; 21(3):82-4. PubMed ID: 10689358
    [No Abstract]   [Full Text] [Related]  

  • 20. G protein-coupled receptors. I. Diversity of receptor-ligand interactions.
    Ji TH; Grossmann M; Ji I
    J Biol Chem; 1998 Jul; 273(28):17299-302. PubMed ID: 9651309
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.